Earnings Per Share, Basic of BridgeBio Oncology Therapeutics, Inc. from 30 Sep 2024 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
BridgeBio Oncology Therapeutics, Inc. quarterly and annual Earnings Per Share, Basic in USD/shares history and change rate from 30 Sep 2024 to 31 Dec 2025.
  • BridgeBio Oncology Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending 31 Dec 2025 was -490, a 54% increase year-over-year.
  • BridgeBio Oncology Therapeutics, Inc. annual Earnings Per Share, Basic for 2025 was -4.3, a 100% increase from 2024.
Source SEC data
View on sec.gov
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

BridgeBio Oncology Therapeutics, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 -490 +586 +54% 01 Oct 2025 31 Dec 2025 8-K 05 Mar 2026
Q3 2025 -1.03* +1,561 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q4 2024 -1,076 01 Oct 2024 31 Dec 2024 8-K 05 Mar 2026
Q3 2024 -1,562 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3

BridgeBio Oncology Therapeutics, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 -4.3 +5,752 +100% 01 Jan 2025 31 Dec 2025 10-K 05 Mar 2026 2025 FY
2024 -5,756 01 Jan 2024 31 Dec 2024 10-K 05 Mar 2026 2025 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.